Prevalence and Characterisation of Patients with Asthma According to Disease Severity in Portugal Findings from the EPI-ASTHMA Pilot Study

Autores da FMUP
Participantes de fora da FMUP
- Joao, C
- Brito, D
- Teixeira, P
- Amorim, L
- Barbosa, MJ
- Bulhoes, C
- Lopes, F
- Pardal, M
- Bernardo, F
- de Sousa, JC
Unidades de investigação
Abstract
Objective: To assess the feasibility of the procedures of EPI-ASTHMA. EPI-ASTHMA is a population-based multicentre stepwise study about the prevalence and characterisation of patients with asthma based on disease severity in Portugal. Methods: A pilot study of EPI-ASTHMA was conducted with adults from three primary care centres. We followed a stepwise approach comprising 4 stages: stage 0-invitation phone call (n similar to 1316); stage 1-telephone interview (n similar to 658); stage 2-clinical assessment with physical examination, diagnostic tests, and patient-reported outcome measures, to confirm the diagnosis of those with possible asthma at stage 1 (n similar to 160); stage 3-characterization of a subgroup of asthma patients by collecting data through a telephone interview, patient file review and CARATm app (n similar to 40), after 3-months. The frequency of asthma was calculated in relation to the entire study population (stage 1) and the frequency of difficult-to-treat/severe asthma in relation to the number of asthma patients (stage 3). Results: From 1305 adults invited, 892 (68%) accepted to participate (stage 0) and 574 (64%; 53[42-67] y; 43% male) were interviewed (stage 1). From those, 148 (26%; 60[46-68] y; 43% male) were assessed at stage 2, and 46 (31%; 51[39-67] y; 44% male) were diagnosed with asthma. Half of these patients (n = 23) accepted to install the app. Stage 3 was completed by 41 (93%) patients, of whom 31 (83%) had asthma confirmed by their file review. A total of 8% of participants had asthma, of those 17% had difficult-to-treat and 5% severe asthma. Conclusion: Attained recruitment rates and the quality of the results confirmed the feasibility of the EPI-ASTHMA stepwise approach. This pilot study provided insight into the improvement of the procedures to be generalized across the country.
© 2022 João et al.
Dados da publicação
- ISSN/ISSNe:
- 1178-6965, 1178-6965
- Tipo:
- Article
- Páginas:
- 1441-1453
- DOI:
- 10.2147/JAA.S381716
- Link para outro recurso:
- www.scopus.com
Journal of Asthma and Allergy Dove Medical Press Ltd.
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 3
Documentos
- Não há documentos
Filiações
Keywords
- asthma; prevalence; epidemiology; severe asthma; difficult-to-treat asthma
Financiamento
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527
Investigador Principal: João de Almeida Lopes da Fonseca
Ensaio Clínico Académico (mINSPIRERS) . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021
Efficiency in Spine Care ? Assessing outcomes and costs to inform healthcare improvement
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2022
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Joao C,Jácome C,Brito D,Teixeira P,Quelhas J,Amorim L,Barbosa MJ,Bulhoes C,Lopes F,Pardal M,Bernardo F,Fonseca J,de Sousa JC. Prevalence and Characterisation of Patients with Asthma According to Disease Severity in Portugal Findings from the EPI-ASTHMA Pilot Study. J Asthma Allergy. 2022. 15. p. 1441-1453. IF:3,200. (3).